Horizon 2020 Project - RESTORE

08.01.2019

Askel is proud to be part of European Commission funded Horizon 2020 research project, RESTORE. The RESTORE project will kick off January 2019 with ten partners from eight European countries with a budget of more than 5.5MEUR for the next 3.5 years. The team will work together to develop an effective approach to manage the unmet clinical need of knee cartilage damage. Askel’s COPLA® Scaffold is at the core of this development.

H2020 logo

Untreated or not-correctly treated cartilage defects are likely to progress towards osteoarthritis (OA), which affects 242 million people globally (costs/patient/year: 10,452€). RESTORE will address the shortfalls of current therapeutic solutions while aiming to reduce the overall burden of OA. For Askel, the RESTORE’s outcomes hold high commercial potential, striving to diminish the onset of OA, reducing hospitalization and time off work. From patient perspective, RESTORE’s outcomes will promote wellbeing and active ageing.

To answer the clinical and societal challenge of knee cartilage defects, RESTORE will develop smart and functional 3D matrices by combining COPLA® Scaffold with nanocarriers and stimuli-responsive nanobiomaterials to modulate inflammatory, cartilage degradation and infection threats. These functional additives will be remotely stimulated and their regeneration activity monitored with an non-invasive wearable and wireless device.

The partners of the RESTORE project are:

INEB-INSTITUTO NATIONAL DE ENGENHARIA BIOMEDICA (Portugal), Coordinator

UNIVERSITY OF OULU (Finland)

UNIVERSITAET ULM (Germany)

HASKOLINN I REYKJAVIK EHF (Iceland)

FUNDATION CIDETEC (Spain)

GÖTEBORGS UNIVERSITET (Sweden)

SINTEF AS (Norway)

UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO (Italy)

ASKEL HEALTHCARE OY (Finland)

3DTECH OY (Finland)

<< Back